欢迎来到范德生物BIOFOUNT
范德生物中国

中文范德生物中文语言

范德生物产品购买购物车
0
搜索
MBM-55_2083622-09-5_产品详情
2083622-09-5
  • names:

    MBM-55

  • CAS号:

    2083622-09-5

    MDL Number:
  • MF(分子式): C28H27FN6O2 MW(分子量): 498.55
  • EINECS: Reaxys Number:
  • Pubchem ID: Brand:BIOFOUNT
MBM-55
货品编码 规格 纯度 价格 (¥) 现价(¥) 特价(¥) 库存描述 数量 总计 (¥)
YZM001489-250mg 250mg ¥ 0.00 ¥ 0.00 Backorder
- +
¥ 0.00
YZM001489-100mg 100mg >97% ¥ 0.00 ¥ 0.00 2-3天
- +
¥ 0.00
快速询价
收起
你想询价的产品
请准确填写您的联系方式,以便为您提供最好的服务。
中文别名
英文别名 MBM-55
CAS号 2083622-09-5
Inchi
InchiKey
分子式 Formula C28H27FN6O2
分子量 Molecular Weight 498.55
溶解度Solubility
性状
储藏条件 Storage conditions 请根据产品建议的存储条件进行存储,Please store the product under the recommended condition sin the description.
产品说明
IntroductionMBM5 (compound 42g) is a potentNIMAelated kinase 2 (Nek2)inhibitor with anIC50of 1 nM. MBM5 shows a 20old or greater selectivity in most kinases with the exception of RSK1 (IC50=5.4 nM) and DYRK1a (IC50=6.5 nM). MBM5 effectively inhibits the proliferation of cancer cells by inducing cell cycle arrest and apoptosis. MBM5 shows antitumor activities, and no obvious toxicity to mice.
Application1
Application2
Application3
MBM-55 (compound 42g) 为有效的NIMA-related kinase 2 (Nek2)抑制剂,IC50值为 1 nM,为其他激酶选择性的 20 倍甚至更高,除了 RSK1 (IC50=5.4 nM) 和 DYRK1a (IC50=6.5 nM)。MBM-55 通过诱导细胞周期停滞和凋亡抑制癌细胞的增殖。具有抗肿瘤活性,且对小鼠没有明显的毒性。MBM-55 (compound 42g) is a potentNIMA-related kinase 2 (Nek2)inhibitor with anIC50of 1 nM. MBM-55 shows a 20-fold or greater selectivity in most kinases with the exception of RSK1 (IC50=5.4 nM) and DYRK1a (IC50=6.5 nM). MBM-55 effectively inhibits the proliferation of cancer cells by inducing cell cycle arrest and apoptosis. MBM-55 shows antitumor activities, and no obvious toxicity to mice[1].
警示图
危险性
危险性警示
安全声明
安全防护
备注
【1】.Xi JB, et al. Structure-based design and synthesis of imidazo[1,2-a]pyridine derivatives as novel and potent Nek2 inhibitors with in vitro and in vivo antitumor activities. Eur J Med Chem. 2017 Jan 27;126:1083-1106.
    对不起,暂无产品评价!
MSDS
SDS 1.0 中文
展开
SDS 1.0 英文
展开
        新闻
        抱歉,暂无数据!
        My title page contents